Breast Neoplasms: all 12,820 studies
Page 110 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Limonene Study in Women With Breast CancerCompletedNCT01046929Phase 1
- Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast CancerCompletedNCT01045304Phase 2
- Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing ChemotherapyWithdrawnNCT01045044
- Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT01044485Phase 1/2
- Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related FatigueCompletedNCT01043913Phase 2
- Evaluation the Diagnostic Ability of the Cancer Detection Technology (CDT) to Detect Breast Cancer Among Women Population Over Age 40Status unknownNCT01043055
- Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or CaregiversCompletedNCT01043003Not applicable
- Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based RegimenCompletedNCT01042925Phase 1/2
- Breast Lymph Node MappingStatus unknownNCT01038908Phase 2
- A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast CancerCompletedNCT01038804Phase 2
- Observation Only Study Involving Participants Enrolled in the CHAT TrialStatus unknownNCT01038466
- Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer TherapyStatus unknownNCT01038258Not applicable
- A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast CancerTerminatedNCT01036113Phase 2
- Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment SequellaTerminatedNCT01035268Phase 3
- Women At Risk: The High Risk Breast Cancer ProgramStatus unknownNCT01034891
- Multi-Media Imagery Program for Breast Cancer Patients (Phase II)CompletedNCT01034215Phase 2
- Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)Status unknownNCT01031030Phase 3
- Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of LifeActive, not recruitingNCT01030250
- A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An AnthracyclineCompletedNCT01027208Phase 2
- A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years OldCompletedNCT01026116Phase 3
- Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast CancerCompletedNCT01025349Phase 2
- Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast CancerCompletedNCT01024582Not applicable
- Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis ModalityWithdrawnNCT01024114
- The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast CancerCompletedNCT01023802
- Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast CancerCompletedNCT01023204Phase 2
- The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation CarriersStatus unknownNCT01022333Phase 1
- Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving TrastuzumabStatus unknownNCT01022086
- Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary ChemotherapyStatus unknownNCT01019616Phase 3
- Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane ResistantCompletedNCT01019577Phase 2
- Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast CancerTerminatedNCT01019512Not applicable
- Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast CancerWithdrawnNCT01018251Not applicable
- Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer SurvivorsCompletedNCT01018108Phase 1
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsCompletedNCT01017185Phase 1
- Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone TherapyCompletedNCT01016665Not applicable
- Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871CompletedNCT01015963
- Efficacy Study of Aminoflavone Prodrug to Treat Breast CancerWithdrawnNCT01015521Phase 2
- Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast CancerCompletedNCT01014715Not applicable
- Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerWithdrawnNCT01013506Phase 2
- Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint PainCompletedNCT01013337Not applicable
- Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerCompletedNCT01009437Phase 1
- Patient Activated Controlled Expansion (PACE) TrialCompletedNCT01009008Not applicable
- Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast CancerWithdrawnNCT01008514Phase 2
- Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast CancerTerminatedNCT01007890
- Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a PilotTerminatedNCT01007695Phase 1
- Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast CancerTerminatedNCT01006785Phase 2
- ELBA: Exemestane and Lapatinib in Advanced Breast CancerWithdrawnNCT01005641Phase 2
- Study of Biomarkers in Tissue Samples From Patients With Breast CancerStatus unknownNCT01004796
- Collecting Information From Patients Enrolled in the Breast Specialized Program of Research ExcellenceCompletedNCT01004562
- Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule FindingCompletedNCT01004081Phase 2
- Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.CompletedNCT01003158Phase 1
- Nipple Sparing Mastectomy - Cosmetic OutcomesCompletedNCT01002014Not applicable
- SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)CompletedNCT01001728Phase 3
- Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy ParticipantsWithdrawnNCT00999557Not applicable
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of LapatinibCompletedNCT00996762Phase 1
- Genomic Structural Variation in Cancer SusceptibilityActive, not recruitingNCT00996710
- Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00994968Phase 2
- ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast CancerWithdrawnNCT00993642Early Phase 1
- F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast CancerCompletedNCT00992706Phase 3
- VEGF Early Imaging for Breast CancerCompletedNCT00991978Early Phase 1
- Weight Fluctuation After Breast Cancer TreatmentCompletedNCT00991653
- Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741CompletedNCT00991263
- Mindfulness and Cancer Mamma - Clinical Trial MBSR Among Women Operated for Breast CancerCompletedNCT00990977Phase 2/3
- A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast AbnormalitiesCompletedNCT00990483Not applicable
- A Multi Modality Surveillance Program for Women At High Risk for Breast CancerActive, not recruitingNCT00989638
- MUC1 Vaccine for Triple-negative Breast CancerCompletedNCT00986609Early Phase 1
- Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast CancerCompletedNCT00983684Phase 3
- Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast CancerCompletedNCT00983424Phase 1
- Concurrent Boost RadiotherapyCompletedNCT00981864Phase 2
- Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast CancerTerminatedNCT00979641Phase 2
- Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant MelanomaCompletedNCT00978913Phase 1
- MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast CancerCompletedNCT00978770Phase 2
- Treatment of T1N0 Invasive Breast Carcinoma by Local Excision ImplantCompletedNCT00977275Phase 1/2
- Investigation of Genetic Determinants of Capecitabine ToxicityCompletedNCT00977119
- Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast CancerCompletedNCT00976365Phase 2
- Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast CancerCompletedNCT00976131Phase 1
- Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.CompletedNCT00974610
- CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)Status unknownNCT00973505
- CYP2D6 Genotype on the Clinical Effect of TamoxifenStatus unknownNCT00973037
- Cone Beam Computed Tomography for Breast ImagingCompletedNCT00972413Phase 1
- Fatigue in Breast Cancer SurvivorsStatus unknownNCT00972400
- Chronic Pain in Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast CancerStatus unknownNCT00971919
- Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast CarcinomaCompletedNCT00970983Not applicable
- CADY Study ICORG 08-01CompletedNCT00968682
- Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)CompletedNCT00968409Phase 1
- Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27CompletedNCT00968214
- Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast CancerCompletedNCT00967824Phase 1/2
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
- Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2Status unknownNCT00967239
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00967031Phase 2
- Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone MastectomyStatus unknownNCT00966888Phase 3
- Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising EnzymesCompletedNCT00966043
- An Observational Study to Assess Response to Tamoxifen in Breast Cancer PatientsCompletedNCT00965939
- Relationship of pAKT to Survival in Patients With Node-Positive Breast CancerCompletedNCT00965276
- A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerWithdrawnNCT00964704Phase 2
- Trial of the Effectiveness of a Nurse Education and Care Program for Breast Cancer Patients Treated With ChemotherapyCompletedNCT00964522Not applicable
- Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryCompletedNCT00963729Phase 3
- Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02CompletedNCT00963417Not applicable
- Tamoxifen Citrate in Patients With Breast CancerStatus unknownNCT00963209Phase 3
- A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast CancerCompletedNCT00960960Phase 1
- Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast CancerCompletedNCT00960336Phase 2